Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial
- Resource Type
- Article
- Source
- The Lancet; February-March 2023, Vol. 401 Issue: 10377 p645-654, 10p
- Subject
- Language
- ISSN
- 01406736; 1474547X